TrialJournal of cancer research and clinical oncology2014

Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.

Edward B Garon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.